Table 3.
Performance of DAS in the Validation Set
Variable | P | AUC | 95% CI |
---|---|---|---|
Total | < .001 | 0.650 | 0.585 to 0.716 |
Sex | |||
Female | .3057 | 0.563 | 0.434 to 0.692 |
Male | < .001 | 0.692 | 0.620 to 0.765 |
Smoking status | |||
Current smoker | < .001 | 0.652 | 0.569 to 0.735 |
Former smoker | .0151 | 0.644 | 0.537 to 0.750 |
Histology | |||
Adenocarcinoma | .3084 | 0.557 | 0.448 to 0.667 |
SCC | .0063 | 0.658 | 0.547 to 0.769 |
Other NSCLC | < .001 | 0.754 | 0.643 to 0.865 |
Stage | |||
I and II | .0124 | 0.675 | 0.546 to 0.804 |
III and IV | < .001 | 0.693 | 0.613 to 0.773 |
Timing of blood draw, months | |||
0-6 | < .001 | 0.740 | 0.634 to 0.846 |
> 6-12 | .0409 | 0.588 | 0.505 to 0.671 |
Abbreviations: AUC, area under the curve; DAS, N1,N12-diacetylspermine; NSCLC, non–small-cell lung cancer; SCC, squamous cell carcinoma.